About
Candesant Biomedical is a clinical-stage company based in San Francisco, California, founded in 2015. The company focuses on developing innovative, non-invasive treatments for excessive sweating and hyperhidrosis, which can greatly affect patients' quality of life. Their primary product, the Brella™ SweatControl Patch™, is an FDA-cleared topical patch designed for adults experiencing excessive sweating. This patch is applied for up to three minutes and can effectively reduce sweating for up to two months. It provides a fast and easy alternative to traditional treatments, with minimal side effects and no recovery time required. Candesant Biomedical is recognized for its novel technology and has received accolades in the medical device industry. The company is led by CEO Niquette Hunt and includes a team of experienced professionals dedicated to improving patient outcomes through effective solutions for dermatological conditions.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2016
-
Annual Revenue $4000000
-
Total Funding $53266864
Location
1718 Church St, Nashville, Tennessee, United States, 37203-0033
